Lipitor keeps on selling, so Pfizer will keep on producing it in Ireland

It's official: Demand for the off-patent drug Lipitor has inspired Pfizer ($PFE) to keep an Irish plant it had slated for closure. Sales in emerging markets, and to a lesser extent the U.S., are behind the change of mind, which saves 160 jobs in Little Island, Cork. Improved productivity at the plant helped, too. Release | More